These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15188146)
1. Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma. Huang Q; Chu PG; Lau SK; Weiss LM Hum Pathol; 2004 Jun; 35(6):769-73. PubMed ID: 15188146 [TBL] [Abstract][Full Text] [Related]
2. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
3. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases. Osunkoya AO; Epstein JI Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186 [TBL] [Abstract][Full Text] [Related]
4. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature. Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389 [TBL] [Abstract][Full Text] [Related]
5. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Tamboli P; Mohsin SK; Hailemariam S; Amin MB Arch Pathol Lab Med; 2002 Sep; 126(9):1057-63. PubMed ID: 12204054 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550 [TBL] [Abstract][Full Text] [Related]
7. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer. Chan E; Garg K; Stohr BA Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185 [TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Genega EM; Hutchinson B; Reuter VE; Gaudin PB Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075 [TBL] [Abstract][Full Text] [Related]
9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
10. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia. Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509 [TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases. Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786 [TBL] [Abstract][Full Text] [Related]
12. Intravesical botryoid adenocarcinoma of the prostate: report of an unusual growth pattern of prostatic carcinoma simulating a urinary bladder tumor. Camilot D; Pizzolitto S; DeMaglio G; Falconieri G Ann Diagn Pathol; 2007 Dec; 11(6):413-6. PubMed ID: 18022125 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Lane Z; Hansel DE; Epstein JI Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358 [TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in ectopic prostatic tissue at dome of bladder: a case report of a patient with urothelial carcinoma of the bladder and adenocarcinoma of the prostate. Gardner JM; Khurana H; Leach FS; Ayala AG; Zhai J; Ro JY Arch Pathol Lab Med; 2010 Sep; 134(9):1271-5. PubMed ID: 20807045 [TBL] [Abstract][Full Text] [Related]
15. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Varma M; Morgan M; Amin MB; Wozniak S; Jasani B Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749 [TBL] [Abstract][Full Text] [Related]
16. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder. Behzatoğlu K Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380 [TBL] [Abstract][Full Text] [Related]
17. Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma. Adley BP; Maxwell K; Dalton DP; Yang XJ Int Braz J Urol; 2006; 32(6):681-7; discussion 687-8. PubMed ID: 17201946 [TBL] [Abstract][Full Text] [Related]
18. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819 [TBL] [Abstract][Full Text] [Related]
20. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity. Curtis MW; Evans AJ; Srigley JR Mod Pathol; 2005 Apr; 18(4):585-90. PubMed ID: 15778694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]